Laurence Rulleau

Laurence Rulleau, PhD, is a seasoned professional in the life sciences sector, currently serving as Managing Partner at CTI Life Sciences Fund since November 2014. Rulleau has held various leadership roles, including Managing Partner at CTI LSF III and Principal, while also being actively involved as a board member for several companies such as Find Therapeutics, PreciThera, Inc., adMare BioInnovations, DalCor Pharmaceuticals, and Liphorus Pharmaceuticals. Rulleau's previous experience includes a role as Partner and Principal at CTI LSF II and serving as a Board Observer at ILKOS THERAPEUTICS Inc. and BOD Member at CDRD. Rulleau holds a Master's degree in viro-immunology from UQAM and a PhD in molecular biology from Université de Montréal.